Sun Pharma Advanced Research Company informs about press release
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharma Advanced Research Company has informed that it enclosed the Press Release titled ‘SPARC Announces Sale of Priority Review Voucher for US $ 195 million (One Hundred and Ninety-Five Million Dollars)’, which the company shall be releasing after sending this letter. The disclosure required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI LODR’) read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 for the Sale of Priority Review Voucher is provided in Annexure A.
The above information is a part of company’s filings submitted to BSE.
